Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Intera Partners in connection with the acquisition of Halon Security
Mandate

Vinge advises Intera Partners in connection with the acquisition of Halon Security

November 05, 2024 M&A Corporate Commercial Employment and Benefits Intellectual Property Banking and Finance

Vinge has advised Intera Equity Partners IV Oy (“Intera Partners”) in connection with the acquisition of Halon Security AB (“Halon”).

Halon is a global leader in email infrastructure software based in Sweden with customers in over 30 countries and a revenue of approximately SEK 49 million.

Halon is a trusted partner for mission-critical email services and service providers and companies that demand high security, scalability and high-volume email handling rely on Halon’s software. Intera Partners‘ investment will contribute to Halon's continued market expansion and development of solutions that meet customers’ changing needs and evolving business, technology and security requirements.

Vinge’s team consisted of among others Jonas Bergström, Carl Sander, Eléonore Friberg, Klara Fäldt and Emma Lundberg (M&A), Helena Göransson, Karl-Gustaw Tobola and Matilda Hamner (Banking and Finance) Jolene Reimerson and Carla Håkansson (Corporate Commercial & IT), Victor Björkheim (Employment), Emma Gustavsson (IP) and Cecilia Loctander (Transaction Support Coordinator).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025